Tissue regeneration through Gene therapy

Anandkumar Nandakumar

Anand has close to 20 years experience in the life sciences industry across medtech, biotech and pharma.

After completing his PhD in Bone tissue engineering, he worked for a medtech start-up leading the development of novel polymer based scaffolds for cardiovascular applications, culminating in a FIH study in young children. After that, Anand spent time in an MNC focusing on vaccine development and later at a scale-up leading the operational readiness of the company’s 1st CAR-T cell therapy facility in the Netherlands.

Anand combines his scientific and technical knowledge with strong program alliance management skills to further innovation and help patients in need.